A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity.
Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present study aimed to establish a bioinformatics pipeline capable of defining and validating NAFLD biomarker candidates based on paired hepatic globa...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0275901 |
Search Result 1
A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity
Published 2022-01-01
Get full text
Article